Evidence map›Paper›PMID 22166235›Full record

ArticleCancer letters2012

Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma.

Nelson S Yee, Weiqiang Zhou, Minsun Lee, Rosemary K Yee

Open access · greenAbstract read
In one paragraph

Article in Cancer letters, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. The Role of TRPM7 in Oncogenesis.International journal of molecular sciences · 2024
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. MgNutrients · 2021
    Review
  10. Transportome Malfunctions and the Hallmarks of Pancreatic Cancer.Reviews of physiology, biochemistry and pharmacology · 2021
    Review
  11. Article
  12. TRP Channels in Digestive Tract Cancers.International journal of molecular sciences · 2020
    Review
  13. Review
  14. Transient Receptor Potential Cation Channels in Cancer Therapy.Medical sciences (Basel, Switzerland) · 2019
    Review
  15. Role of ion channels in gastrointestinal cancer.World journal of gastroenterology · 2019
    Review
  16. TRPC6 in simulated microgravity of intervertebral disc cells.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2018
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nelson S YeeDivision of Hematology-Oncology, Department of Medicine, Penn State College of Medicine, Pennsylvania State University, 500 University Drive, Hershey, PA 17033, USA. nyee@hmc.psu.edu
Weiqiang Zhou
Minsun Lee
Rosemary K Yee
University of Iowa · USPennsylvania State University · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
NCI NIH HHS P30 CA 086862NCI NIH HHS P30 CA086862
6 · The paper itself

Abstract

The transient receptor potential TRPM7 ion channel is required for cellular proliferation in pancreatic epithelia and adenocarcinoma. To elucidate the mechanism that mediates the function of TRPM7, we examined its role in survival of pancreatic cancer cells. RNA interference-mediated silencing of TRPM7 did not induce apoptotic cell death. TRPM7-deficient cells underwent replicative senescence with up-regulation of p16(CDKN2A) and WRN mRNA. The combination of anti-TRPM7 siRNA and gemcitabine produced enhanced cytotoxicity as compared to gemcitabine alone. Thus, TRPM7 is required for preventing senescence, and modulation of TRPM7 expression may help improve treatment response of pancreatic cancer by combining with apoptosis-inducing agents.

Indexed as

Cellular SenescenceRNA InterferenceAdenocarcinomaAntimetabolites, AntineoplasticApoptosisBlotting, WesternCell Line, TumorCell ProliferationCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p27DeoxycytidineExodeoxyribonucleasesGemcitabineHumansPancreatic NeoplasmsReal-Time Polymerase Chain ReactionAntimetabolites, AntineoplasticCDKN1B protein, humanCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p27DeoxycytidineExodeoxyribonucleasesGemcitabineRecQ HelicasesRNA, MessengerRNA, Small InterferingWerner Syndrome HelicaseWRN protein, human

Identifiers

PMID22166235
PMCPMC3303226
OpenAlexW2090164016

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.